Biology of Bone Sarcomas and New Therapeutic Developments.

Biology of Bone Sarcomas and New Therapeutic Developments.
复制标题

DOI:
10.1007/s00223-017-0372-2
复制
发表时间:
2018-03
影响因子:
4.2
通讯作者:
Heymann D
Heymann D
中科院分区:
医学3区
文献类型:
--
作者:
Brown HK;Schiavone K;Gouin F;Heymann MF;Heymann D

文献摘要

参考文献

被引文献

相似文献

骨肉瘤是属于间叶肿瘤家族的肿瘤,并且构成高度异质性的肿瘤组。三种主要的骨肉瘤是骨肉瘤、尤文氏肉瘤和软骨肉瘤,每一种在不同的组织学实体中细分。其临床特征是发病率和死亡率相对较高,尤其是在儿童和青少年中。虽然这些肿瘤在组织学、分子和遗传学上是异质的,但它们在发病机制中共同涉及局部微环境。本文综述了其特点,并总结了骨肉瘤领域的主要治疗进展。
Bone sarcomas are tumours belonging to the family of mesenchymal tumours and constitute a highly heterogeneous tumour group. The three main bone sarcomas are osteosarcoma, Ewing sarcoma and chondrosarcoma each subdivided in diverse histological entities. They are clinically characterised by a relatively high morbidity and mortality, especially in children and adolescents. Although these tumours are histologically, molecularly and genetically heterogeneous, they share a common involvement of the local microenvironment in their pathogenesis. This review gives a brief overview of their specificities and summarises the main therapeutic advances in the field of bone sarcoma.
癌症相关的间充质基质通过NF-κB激活对肿瘤内酸中毒的响应,促成骨肉瘤细胞的干性。
DOI: 10.1002/ijc.30540
发表时间: 2017-03-15
影响因子: 6.4
作者:
Avnet S;Di Pompo G;Chano T;Errani C;Ibrahim-Hashim A;Gillies RJ;Donati DM;Baldini N
通讯作者: Baldini N
PD-1和PD-L1检查点信号传导抑制癌症免疫疗法:机制,组合和临床结果。
DOI: 10.3389/fphar.2017.00561
发表时间: 2017
影响因子: 5.6
作者:
Alsaab HO;Sau S;Alzhrani R;Tatiparti K;Bhise K;Kashaw SK;Iyer AK
通讯作者: Iyer AK
DOI: 10.1182/blood-2009-08-237628
发表时间: 2010-01-07
期刊: BLOOD
影响因子: 20.3
作者:
Cackowski, Frank C.;Anderson, Judith L.;Roodman, G. David
通讯作者: Roodman, G. David
DOI: 10.1007/s00280-012-1968-x
发表时间: 2012-12-01
影响因子: 3
作者:
Bernstein-Molho, Rinat;Kollender, Yehuda;Merimsky, Ofer
通讯作者: Merimsky, Ofer
DOI: 10.1155/2012/230298
发表时间: 2012
影响因子: --
作者:
Broadhead ML;Choong PF;Dass CR
通讯作者: Dass CR